FAQs about 504 Plans
This resource from Children’s Hospital of Philadelphia provides information on 504 plans, which ensure reasonable accommodations for children who qualify.
Showing 1 - 10 of 20 results
This resource from Children’s Hospital of Philadelphia provides information on 504 plans, which ensure reasonable accommodations for children who qualify.
Adolescents with chronic illnesses, including arthritis, need guidance and a plan for the future in order to safely transition to an adult provider.
Sponsored by the Arthritis Foundation, Camp JRA offers a place for children with arthritis to have fun, make new friends and learn how to take control of their disease.
The Plastic Bronchitis Foundation provides information about plastic bronchitis, research into treatments, family support services and more. The group also helps raise awareness of plastic bronchitis, funds research into the disease and assists patients and their families with treatment-related travel expenses.
The mission of the LGD Alliance is to improve the care of patients with lymphangiomatosis and Gorham's disease by promoting research that will identify effective treatments and ultimately a cure. On this site, you’ll find patient resources including patient support services, patient registry, a physician directory and more. You'll also find access to disease information, research resources and latest news and events.
Provides information and step-by-step instructions on how to self-administer Otrexup™ (methotrexate) injection for subcutaneous use for the treatment of rheumatoid arthritis.
Watch this video of lymphatic flow and drainage from the Jill and Mark Fishman Center for Lymphatic Disorders at CHOP.
The goal of this tip sheet from the Division of Rheumatology at Children’s Hospital of Philadelphia (CHOP) is to help patients and families get a clear understanding of the specialty medication process, the tools you need to order specialty medication refills and who to call if you have a concern.
View this presentation from Christopher Smith, MD, PhD, with the Lymphatic Education & Research Network.
This pathway is to be used for infants from birth to 1 year of age, admitted to an intensive care unit, with concern for lymphatic flow disorders without history of surgical/traumatic chylothorax, congenital heart disease, or isolated lymphatic mass.